Code | 0816C | ||||||||||
MA number | 59/0368/16-S | ||||||||||
Product Form: | sol inf 1x100 ml/10 g (fľ.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Octapharma (IP) SPRL, Belgium | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 17.08.2016 |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Panzyga_12.2020.doc |
PIL: | PIL_Panzyga_12.2020.doc |
Safety feature | Yes |
Data update: | 14.01.2021 |